Navigation Links
D-Pharm Raises NIS 85 Million in Rights Offering and Initial Public Offering (IPO) on the Tel Aviv Stock Exchange (TASE)
Date:8/17/2009

REHOVOT, Israel, August 17 /PRNewswire/ -- D-Pharm announced today the completion of a financial round, which yielded NIS 85 million (approximately $23M USD) to fund the Company's late stage clinical stroke program. The financial round combined a rights offering of NIS 57 million and an Initial Public Offering (IPO) of NIS 28 million. The IPO was oversubscribed and the unit price was set at 133 NIS, 13% higher than the minimum price. The company's pre-money valuation was NIS 120 million.

D-Pharm will commit most of the proceeds of the rights issue and the IPO towards the forthcoming pivotal Phase III clinical trial of DP-b99 in patients with acute ischemic stroke (study acronym - MACSI). An Investigational New Drug (IND) application for the Phase III clinical trial of DP-b99 was approved by the US Food and Drug Administration (FDA) in June 2009. The trial will enroll 770 patients with moderately severe ischemic stroke in more than 100 medical centers in North America, Europe, South Africa and Israel.

Clal Biotechnology CEO and D-Pharm's Chairman of the Board Ruben Krupik said: "This is a unique offering because the current shareholders provided most of the financing. We gave the public the opportunity to participate, while taking most of the risk upon ourselves."

D-Pharm's CEO, Dr. Alex Kozak, said: "Now we are set to move full steam ahead with the Phase III study of DP-b99. I am happy to see Israeli public sector investors supporting an advanced clinical stage company like D-Pharm. I hope that our IPO opens the door to the flotation of other companies, especially in the biotech industry".

The offering was underwritten by CLAL Finance Underwriting Ltd., as well as Rosario Underwriting Services (AS) Ltd. and Meitav Underwriting and Investment Ltd.

About DP-b99

DP-b99 is a unique neuroprotective drug that addresses an array of brain damaging processes
'/>"/>

SOURCE D-Pharm Ltd
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. D-Pharm Submits Investigational New Drug Application and Special Protocol Assessment to the FDA for Phase III Trial of DP-b99 in Acute Stroke Patients
2. Globus Medical Raises $110 Million in Series E Financing Round
3. EntreMed Raises $20 Million to Support Clinical Development Program
4. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
5. Romark Laboratories Raises $18 Million in Institutional Financing
6. Light Sciences Oncology Raises $40.1 Million in Series C Financing
7. Celator Pharmaceuticals Raises Series C Financing in Excess of $22.5 Million
8. ESBATech Raises Additional CHF 23M (USD 22M), Extending Series B Venture Financing
9. Ironwood Raises $50 Million to Advance Linaclotide Through Phase 3
10. Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million
11. Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... YORK , Dec. 18, 2014 Somewhere ... addressing hearing health was forgotten. But Audicus , ... to hear better this new year. Hearing ... facing the aging population, though it is often unaddressed. ... in four has a hearing aid, mainly due to ...
(Date:12/19/2014)... REDWOOD CITY, Calif., Dec. 18, 2014 ... on the development of medical diagnostics based on ... of gas flow, today announced financial results for ... 30, 2014. "Following the completion of ... well positioned to maximize the recently initiated CoSense® ...
(Date:12/19/2014)... , Dec. 18, 2014   Aratana ... a biopharmaceutical company focused on the licensing, development ... today announced positive results from its pivotal field ... for treating pain in dogs with osteoarthritis.  In ... pain assessment scores that were statistically significant compared ...
Breaking Medicine Technology:Audicus Will Help People Resolve to Hear Better in 2015 2Capnia Reports Third Quarter 2014 Financial Results 2Capnia Reports Third Quarter 2014 Financial Results 3Capnia Reports Third Quarter 2014 Financial Results 4Capnia Reports Third Quarter 2014 Financial Results 5Capnia Reports Third Quarter 2014 Financial Results 6Capnia Reports Third Quarter 2014 Financial Results 7Capnia Reports Third Quarter 2014 Financial Results 8Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5
... Nov. 2, 2010 Cambrex Corporation (NYSE: CBM ... Zenara Pharma, a Hyderabad, India based pharmaceutical company focused on ... Highlights To be named ... global suppliers to the large and growing Nicotine Replacement Therapy ...
... Charleston Laboratories, Inc., an emerging specialty pharmaceutical ... (OINV) in opioid pharmaceuticals, announced today that it ... government under the Qualifying Therapeutic Discovery Project (QTDP) ... award to advance the development of its lead ...
Cached Medicine Technology:Cambrex Acquires Stake in Zenara Pharma 2Cambrex Acquires Stake in Zenara Pharma 3Cambrex Acquires Stake in Zenara Pharma 4Charleston Laboratories, Inc. Awarded a Qualifying Therapeutic Discovery Project (QTDP) Grant Under the U.S. Patient Protection and Affordable Care Act of 2010 2
(Date:12/21/2014)... When families in Coral Gables get hit with a ... answer is Lice Troopers . Located at 2100 Ponce ... center will be the new go-to resource for families looking ... of harmful chemicals or pesticides. , The new ... the company’s first clinic (located at 1005 Kane Concourse, Suite ...
(Date:12/21/2014)... December 21, 2014 The number of ... a consolidated litigation underway in New Jersey, Bernstein Liebhard ... of 1,375 claims involving the birth control IUD have ... lawsuits were filed by women who allege spontaneous migration ... to uterine perforations and other complications they were inadequately ...
(Date:12/21/2014)... SCI explores disability in sports ... barriers for disabled athletes with Aaron Scheidies , ... condition called juvenile macular degeneration, where he loses his ... his athletic ambitions to his vision and how he ... pioneer the way for other blind and visually impaired ...
(Date:12/21/2014)... Virginia (PRWEB) December 21, 2014 Concept Plus, ... and engineering firm headquartered in Fairfax, VA., today announced ... of its Fast 50 list, which ranks the fastest growing ... rate from 2009 to 2013. , This is the first ... and it ranked # 20 with a 95.92% compound annual ...
(Date:12/20/2014)... (PRWEB) December 20, 2014 An improving ... sector have benefited the Massage Services industry ... characteristics of industry products, the anticipated 1.0% annualized increase ... has provided consumers with the means to afford additional ... received a massage in a given year has declined ...
Breaking Medicine News(10 mins):Health News:All-Natural Florida Lice Removal Company Opens New Lice Treatment Salon In South Florida 2Health News:Mirena Lawsuits Approach 1,400 in Bergen County Litigation, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuits Approach 1,400 in Bergen County Litigation, Bernstein Liebhard LLP Reports 3Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 2Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 3Health News:Concept Plus, LLC. Named One of Washington Technology’s Fast 50 2Health News:Massage Services in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Massage Services in the US Industry Market Research Report from IBISWorld Has Been Updated 3
... a severe stroke generally improves the patients, lives and ... neurologists at the University of Rochester Medical Center. , ... perspective a decision that is nearly always painful and ... aggressive surgery after a catastrophic stroke is worth it. ...
... Improved patient-oriented research in Europe will benefit European citizens ... of scientific discoveries from the laboratory bench to the ... world this effort will be of great importance for ... of society as a whole. , To achieve ...
... will affect more than 78 million U.S. baby ... can resolve their vision needs to avoid readers.ROCHESTER, ... of the #1 multifocal lens design, has launched ... of raising U.S. awareness of presbyopia and multifocal ...
... Following a successful two-year campaign of support for the ... Cutlery has announced that it is extending its support ... donated more than $274,000 to Go Red For Women ... $74,000 raised through a 10 percent contribution from the ...
... been proclaimed as "World Glaucoma Day" by glaucoma specialists ... Organization, more than five million people, many of African ... lacked the opportunity to get tested for Earlier Glaucoma ... Dr. Robert Welsh, a Rotarian, a world-renowned Eye Surgeon ...
... insurance store in Mechanicsburg to hold grand opening on ... first pair of health insurance retail stores, Highmark Direct, ... Pennsylvania will celebrate its grand opening at the Silver ... Saturday, March 21. During the grand opening, individuals, families ...
Cached Medicine News:Health News:Weighing the options after life-altering stroke 2Health News:Weighing the options after life-altering stroke 3Health News:Weighing the options after life-altering stroke 4Health News:Better health and prosperity in Europe via improved clinical research 2Health News:Bausch & Lomb Launches Multi-Tiered U.S. Consumer Education Initiative to Raise Awareness of Presbyopia 2Health News:Bausch & Lomb Launches Multi-Tiered U.S. Consumer Education Initiative to Raise Awareness of Presbyopia 3Health News:CUTCO Cutlery Extends Its Support of Go Red For Women 2Health News:Welsh 'Self-Test' to Help Cure Glaucoma on World Glaucoma Day 2Health News:Highmark Retail Store to Celebrate Grand Opening 2
... Implant (KGTI) system offers the latest technology ... MPJ. The implant system is anatomically designed ... ,The KGTI is the most advanced reconstructive ... on the market today. The system consists ...
... Nerve Electrodes provide direct cranial nerve ... patented circumferential design provides sensitive contact ... stable real-time recordings. This unique approach ... the removal of acoustic neuromas, microvascular ...
... Ad-Techs Model CMU Cortical Mapping Unit ... of recording EEGs from exposed cortex during ... each electrode plate can be positioned independently ... clamp provides two alternative mounting locations and ...
An ambulatory recorder can help the patient be more comfortable and at ease as well as increasing an EEG laboratory's recording capacity....
Medicine Products: